Top drugs and pharmaceutical companies of 2019 by revenues
Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-
US DMF filings indicate a robust API industry, with multiple first-to-file challenges
This week, PharmaCompass brings you a compilation of the Drug Master Files (DMFs) updates at